Axovant Announces Expansion of Dementia Drug Development Pipeline and Reports Financial Results for the Second Fiscal Quarter and Six Months Ended September 30, 2015
Go back to Axovant Announces Expansion of Dementia Drug Development Pipeline and Reports Financial Results for the Second Fiscal Quarter and Six Months Ended September 30, 2015| Axion Spatial Imaging Inc (NASDAQ: AXON) | Delayed: 433.04 +23.01 (5.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $410.03 | 52 Week High | $21.30 | |||
| Open | $414.44 | 52 Week Low | $8.86 | |||
| Day High | $441.11 | P/E | N/A | |||
| Day Low | $414.44 | EPS | $0.00 | |||
| Volume | 1,108,332 | |||||
